Created with Sketch. BackAbano 2019 Annual Report 27/8/2019, 9:18 am ANNREP. Advanced Search. Abano Healthcare Group Limited is the operator of one of the largest trans-Tasman dental groups, comprising Lumino The Dentists in New Zealand and Maven Dental Group in Australia. If you require further searching capabilities for announcements please email: email@example.com Back Abano Shareholder Newsletter June 2018 8/6/2018, 9:37 am GENERAL BackAbano Interim Report 8/2/2019, 8:40 am INTERIM. • 22 December 2020, close of trading: Cessation of quotation of Abano shares and de-listing of Abano from NZX Holders of Abano shares at 5.00 pm (NZ time) on the record date will be entitled to receive the Scheme consideration in cash, which will be paid on the implementation date (expected to occur on 22 December 2020). Abano Healthcare Group Limited is pleased to present the Interim Report and Half Year Review Letter for the six months ended 30 November 2018. MEMO: ABA: Abano Healthcare Group Limited ("ABA") -Intention to delist: 08/12/20 : 0: 37: 08/12/20: Last post NZX News: Created with Sketch. Claim your IR profile Are you a Company Director ? Abano Healthcare Group LImited has released its Annual Report for the year ended 31 May 2019. Created with Sketch. Customise Ticker. Created with Sketch. NZX Regulation (“NZXR”) advises that, following the release of the announcement by Abano Healthcare Group Limited (“ABA”) today at 9.01am, trading in ABA ordinary shares will resume at market open. Please contact NZX Product Operations on +64 4 496 2853 or productoperations@nzx… Announcements ASX Announcements NSX Announcements NZX Announcements. Recent Announcements. Abano Healthcare Group Limited (NZX: ABA) advises that Dr Tracey Batten has been appointed to the Board, effective from 23 May 2018. Further to the announcement made by Abano Healthcare Group Limited on 25 November 2020 in relation to its Scheme of Arrangement with Adams NZ Bidco Limited (“Scheme”), NZX Operations (“NZXO”) advises of the intention for ABA to delist from the NZX Main Board (“NZSX”). The shares in Abano were acquired by Adams NZ Bidco Limited on the 22 December 2020 and the company de-listed from the NZX on that date. Put your Investment Case to Hotcopper's 700K monthly unique visitors. Following Abano’s transition to focus solely on the $11-billion trans-Tasman dental market, Board composition has been reviewed to ensure there is an appropriate mix of relevant knowledge, expertise and experience. Abano Healthcare Group Limited (NZX: ABA) advises that the scheme of arrangement, under which Adams NZ Bidco Limited will acquire all of the shares in Abano for NZ$5.70 in cash per share, has been approved by shareholders by an overwhelming majority, at the Special Meeting today in Auckland. Created with Sketch. The issue price has been determined, in accordance with the DRP, as the volume weighted average sale price for all Abano shares sold on the NZX over the five trading days immediately following the record date of 9 January 2018, less a 2.5% discount.